Find trials
Search tips

Circulating Tumor Cells in Patients with Cholangiocarcinoma

Overview

About this study

The overall goal of this research is to measure the circulating tumor cell in the peripheral blood and investigate the association between circulating tumor cell level and tumor characteristics and prognosis.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients diagnosed with cholangiocarcinoma at Mayo Clinic Rochester 
  • Patients with a tumor size >5cm or CA19-9>1,000 or multifocal, or bilobar or metastatic disease  

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lewis Roberts, M.B., Ch.B., Ph.D.

Closed for enrollment

Contact information:

Nasra Giama D.N.P., R.N.

(507) 538-0097

Giama.Nasra@mayo.edu

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20315401

Mayo Clinic Footer